These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
118 related items for PubMed ID: 7740479
1. Evaluation of recombinant human factor IX: pharmacokinetic studies in the rat and the dog. Keith JC, Ferranti TJ, Misra B, Frederick T, Rup B, McCarthy K, Faulkner R, Bush L, Schaub RG. Thromb Haemost; 1995 Jan; 73(1):101-5. PubMed ID: 7740479 [Abstract] [Full Text] [Related]
2. Biodistribution and pharmacokinetics of transgenic pig-produced recombinant human factor IX (rhFIX) in rats. Chang CH, Chou TK, Yang CY, Chang TJ, Wu YH, Lee TW. In Vivo; 2008 Jan; 22(6):693-7. PubMed ID: 19180993 [Abstract] [Full Text] [Related]
9. Stable and high-level production of recombinant Factor IX in human hepatic cell line. de Castilho Fernandes A, Fontes A, Gonsales N, Swiech K, Picanco-Castro V, Faca S, Covas D. Biotechnol Appl Biochem; 2011 Jan; 58(4):243-9. PubMed ID: 21838798 [Abstract] [Full Text] [Related]
11. Variability of in vivo recovery of factor IX after infusion of monoclonal antibody purified factor IX concentrates in patients with hemophilia B. The Mononine Study Group. White GC, Shapiro AD, Kurczynski EM, Kim HC, Bergman GE. Thromb Haemost; 1995 May; 73(5):779-84. PubMed ID: 7482403 [Abstract] [Full Text] [Related]
12. Pharmacokinetics and pharmacodynamics of a humanized monoclonal antibody to factor IX in cynomolgus monkeys. Benincosa LJ, Chow FS, Tobia LP, Kwok DC, Davis CB, Jusko WJ. J Pharmacol Exp Ther; 2000 Feb; 292(2):810-6. PubMed ID: 10640322 [Abstract] [Full Text] [Related]
15. Prophylaxis in factor IX deficiency product and patient variation. Kisker CT, Eisberg A, Schwartz B, Mononine Study Group. Haemophilia; 2003 May; 9(3):279-84. PubMed ID: 12694518 [Abstract] [Full Text] [Related]
16. Preclinical pharmacology of 2-methoxyantimycin A compounds as novel antitumor agents. Wang H, Li M, Rhie JK, Hockenbery DM, Covey JM, Zhang R, Hill DL. Cancer Chemother Pharmacol; 2005 Sep; 56(3):291-8. PubMed ID: 15883820 [Abstract] [Full Text] [Related]
17. PROLONG-9FP clinical development program--phase I results of recombinant fusion protein linking coagulation factor IX with recombinant albumin (rIX-FP). Santagostino E. Thromb Res; 2013 Mar; 131 Suppl 2():S7-10. PubMed ID: 23537724 [Abstract] [Full Text] [Related]
18. Pilot production of recombinant human clotting factor IX from transgenic sow milk. Sun YL, Chang YS, Lin YS, Yen CH. J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Jun 01; 898():78-89. PubMed ID: 22578515 [Abstract] [Full Text] [Related]
19. Preclinical studies of recombinant factor IX. Schaub R, Garzone P, Bouchard P, Rup B, Keith J, Brinkhous K, Larsen G. Semin Hematol; 1998 Apr 01; 35(2 Suppl 2):28-32. PubMed ID: 9565164 [Abstract] [Full Text] [Related]